CVS Health Corporation
Organization details
- Legal name
- CVS Health Corporation
- Former names
- CVS Caremark Corp CVS Corp Melville Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Consumer Staples
- SIC code
- 5912 — Retail-Drug Stores and Proprietary Stores
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Woonsocket
- Headquarters state / province
- Rhode Island
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CVS
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000064803
- EIN
- 05-0494040
- Wikidata ID
- Q624375
Board of directors
-
Alecia A. Decoudreaux · DirectorSince 2023
-
Anne A. Finucane · DirectorSince 2023
-
C. David Brown II · DirectorSince 2023
-
Douglas H. Shulman · DirectorSince 2024
-
Edward J. Ludwig · DirectorSince 2023
-
Fernando Aguirre · DirectorSince 2023
-
Guy P. Sansone · DirectorSince 2024
-
J. David Joyner · Director · President, CEO and ChairSince 2024
-
J. Scott Kirby · DirectorSince 2023
-
Jean Pierre Millon · DirectorSince 2023
-
Jeffrey R. Balser · DirectorSince 2023
-
John E. Gallina · DirectorSince 2026
-
Karen S. Lynch · Director · President and CEOSince 2023
-
Larry Robbins · DirectorSince 2024
-
Leslie Norwalk V · DirectorSince 2024
-
Mary L. Schapiro · DirectorSince 2023
-
Michael F. Mahoney · DirectorSince 2023
-
Nancy Ann Deparle · DirectorSince 2023
-
Roger N. Farah · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 14, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
90.7%
-
92.9%
-
93.6%
-
96.0%
-
96.0%
-
96.0%
-
97.4%
-
98.4%
-
98.5%
-
98.6%
-
98.8%
-
98.9%
-
99.1%
Board connections
15 of this board's directors also sit on 20 other boards.
- via Edward J. Ludwig and Michael F. Mahoney
- via John E. Gallina
- via Leslie Norwalk V
- via Karen S. Lynch
- via Michael F. Mahoney
- via Guy P. Sansone
- via Larry Robbins
- via Jeffrey R. Balser
- via Leslie Norwalk V
- via Nancy Ann Deparle
- via Mary L. Schapiro
- via Leslie Norwalk V
- via Douglas H. Shulman
- via Guy P. Sansone
- via Fernando Aguirre
- via Roger N. Farah
- via Karen S. Lynch
- via J. Scott Kirby
- via Roger N. Farah
- via Anne A. Finucane
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $2,001,315
- 1 purchase by 1 insider
- Sold, last 12 months
- $323,709,755
- 8 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 6, 2026 | Shah Prem S Officer (EVP and Group President) | Open-market purchase | +23,855 | $83.90 | $2,001,315 |
| Jun 26, 2026 | Clark James David Officer (SVP, Cont & Chief Acct Officer) | Shares withheld for tax | −454 | $90.98 | $41,305 |
| May 31, 2026 | Brian Newman Officer (EVP, Chief Financial Officer) | Shares withheld for tax | −2,478 | $90.98 | $225,448 |
| May 31, 2026 | Compton-Phillips Amy Officer (EVP, Chief Medical Officer) | Shares withheld for tax | −7,618 | $90.98 | $693,086 |
| May 21, 2026 | Fernando Aguirre Director | Sold back to the company | −1,563 | $93.50 | $146,141 |
| May 21, 2026 | Larry Robbins Director | Open-market sale | −370,462 | $93.45 | $34,619,674 |
| May 20, 2026 | Fernando Aguirre Director | Sold back to the company | −30,437 | $93.78 | $2,854,382 |
| May 20, 2026 | Larry Robbins Director | Open-market sale | −797,628 | $93.48 | $74,562,265 |
| May 20, 2026 | Larry Robbins Director | Open-market sale | −152,691 | $94.81 | $14,476,634 |
| May 20, 2026 | Larry Robbins Director | Open-market sale | −66,881 | $95.67 | $6,398,505 |
| May 20, 2026 | Larry Robbins Director | Open-market sale | −800 | $96.28 | $77,024 |
| May 19, 2026 | Larry Robbins Director | Open-market sale | −1,983,387 | $94.45 | $187,330,902 |
| May 19, 2026 | Larry Robbins Director | Open-market sale | −151 | $95.18 | $14,372 |
| May 14, 2026 | Fernando Aguirre Director | Grant or award | +1,563 | $97.15 | $151,845 |
| May 14, 2026 | Jeffrey R. Balser Director | Grant or award | +2,058 | $97.15 | $199,935 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about CVS Health Corporation
Who is the CEO of CVS Health Corporation?
J. David Joyner is CVS Health Corporation's President and CEO.
How many directors are on CVS Health Corporation's board?
CVS Health Corporation's board has 19 directors: Alecia A. Decoudreaux, Anne A. Finucane, C. David Brown II, Douglas H. Shulman, Edward J. Ludwig, Fernando Aguirre, Guy P. Sansone, J. David Joyner, J. Scott Kirby, Jean Pierre Millon and 9 others.
Are CVS Health Corporation insiders buying or selling shares?
Over the last 12 months, CVS Health Corporation insiders bought $2.0 million of shares in 1 purchase and sold $323.7 million of shares in 8 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="cvs-health-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.